24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Chengdu Kanghong Pharma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:27
Cisco posts its fastest growth in 15 years with about 8,000 fewer employees than two years ago
14:02
Colette Kress helped bring Israel to the heart of Nvidia's AI business. Now she's in charge.
13:49
Microsoft outage drags into a second day, disrupting businesses and governments worldwide
10:43
When teams can build faster than they can agree
More stories
Buzz
Most popular
Daily
Weekly
1
“The next Palo Alto Networks has already been born, and it is probably in Tel Aviv”
2
CrowdStrike's business chief: "We're long on Israel and we're not going anywhere"
3
The race to replace Jensen Huang: Nvidia's potential successors include an Israeli executive
4
Qualcomm's "performance-focused" layoffs reach India, but employees describe a broader restructuring
5
Palo Alto’s $25 billion CyberArk deal was worth $21 billion at closing. The shares are now worth $37 billion
More news
Chengdu Kanghong Pharma
2 stories about Chengdu Kanghong Pharma
Chengdu Kanghong Pharma Solidifies Ownership of Israeli Medical Device Company
27.09.18
|
Lilach Baumer
The company paid $7 million in 2017 for 19% of IOPtima, a developer of minimally invasive devices for eye surgery
Shenzhen-listed Pharma Company to Acquire Tel Aviv-based Medtech Company IOPtima
21.11.17
|
Lilach Baumer
The Chengdu Kanghong Pharma Group will buy Tel Aviv-based IOPtima in four stages, the latter announced Tuesday through its parent company listed on the Tel Aviv Stock Exchange